PMC:7408073 / 72053-72268 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2563","span":{"begin":113,"end":116},"obj":"Gene"},{"id":"2585","span":{"begin":81,"end":89},"obj":"Species"},{"id":"2615","span":{"begin":9,"end":21},"obj":"Disease"},{"id":"2616","span":{"begin":58,"end":66},"obj":"Disease"},{"id":"2617","span":{"begin":72,"end":80},"obj":"Disease"}],"attributes":[{"id":"A2563","pred":"tao:has_database_id","subj":"2563","obj":"Gene:59272"},{"id":"A2585","pred":"tao:has_database_id","subj":"2585","obj":"Tax:9606"},{"id":"A2615","pred":"tao:has_database_id","subj":"2615","obj":"MESH:D006973"},{"id":"A2616","pred":"tao:has_database_id","subj":"2616","obj":"MESH:C000657245"},{"id":"A2617","pred":"tao:has_database_id","subj":"2617","obj":"MESH:D003920"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Notably, hypertensive (the most frequent comorbidity with COVID-19) and diabetic patients are often treated with ACE inhibitors (ACEIs) and/or with ARBs, suggesting a possible positive correlation [135,136,137,138]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T355","span":{"begin":58,"end":66},"obj":"Disease"}],"attributes":[{"id":"A355","pred":"mondo_id","subj":"T355","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Notably, hypertensive (the most frequent comorbidity with COVID-19) and diabetic patients are often treated with ACE inhibitors (ACEIs) and/or with ARBs, suggesting a possible positive correlation [135,136,137,138]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T892","span":{"begin":165,"end":166},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Notably, hypertensive (the most frequent comorbidity with COVID-19) and diabetic patients are often treated with ACE inhibitors (ACEIs) and/or with ARBs, suggesting a possible positive correlation [135,136,137,138]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T62420","span":{"begin":113,"end":127},"obj":"Chemical"},{"id":"T88754","span":{"begin":117,"end":127},"obj":"Chemical"},{"id":"T52738","span":{"begin":129,"end":134},"obj":"Chemical"}],"attributes":[{"id":"A65154","pred":"chebi_id","subj":"T62420","obj":"http://purl.obolibrary.org/obo/CHEBI_35457"},{"id":"A17139","pred":"chebi_id","subj":"T88754","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A24311","pred":"chebi_id","subj":"T52738","obj":"http://purl.obolibrary.org/obo/CHEBI_35457"}],"text":"Notably, hypertensive (the most frequent comorbidity with COVID-19) and diabetic patients are often treated with ACE inhibitors (ACEIs) and/or with ARBs, suggesting a possible positive correlation [135,136,137,138]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T356","span":{"begin":0,"end":215},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Notably, hypertensive (the most frequent comorbidity with COVID-19) and diabetic patients are often treated with ACE inhibitors (ACEIs) and/or with ARBs, suggesting a possible positive correlation [135,136,137,138]."}

{"project":"2_test","denotations":[{"id":"32708755-32171062-20678910","span":{"begin":198,"end":201},"obj":"32171062"},{"id":"32708755-32222168-20678911","span":{"begin":202,"end":205},"obj":"32222168"},{"id":"32708755-32222169-20678912","span":{"begin":206,"end":209},"obj":"32222169"},{"id":"32708755-32665962-20678913","span":{"begin":210,"end":213},"obj":"32665962"}],"text":"Notably, hypertensive (the most frequent comorbidity with COVID-19) and diabetic patients are often treated with ACE inhibitors (ACEIs) and/or with ARBs, suggesting a possible positive correlation [135,136,137,138]."}